• Corporate
  • Job postings
  • Articles
  • Patients
  • General

The TIES® System represented at major political event

The TIES® Implant and Lid will be represented at Almedalsveckan, an annual political event taking place in Visby, Sweden between the 3rd and 10th of July this year. The Swedish research institute, Swerea will display the solution as an outstanding example of the possibilities using revolutionary 3D manufacturing technology towards patients. OstomyCure has collaborated with Swerea regarding high quality testing of the TIES® System, to ensure safety for the patients.

Latest update on TIES Solution


Message from CEO Ostomycure Dr Benedict Broenniman M.D.

OstomyCure AS Appoints new Chief Medical Officer


OstomyCure today announced the appointment of Cindy Wong, M.D. as Chief Medical Officer (CMO).

Article in IA Journal: Issue 233 Autumn 2016


OstomyCure AS has been published in The Ileostomy & Internal Pouch Support Groups latest issue of the IA Journal.

Experienced Chief Commercial Officer Joins OstomyCure AS


OstomyCure AS engages Morten Gunvad, currently founder and Head of GP Consulting GmbH, as Chief Commercial Officer of the TIES® System.

Significant Breakthrough for Stoma Patients


Aimed to dramatically improve the patient’s quality of life, the TIES® System, a new concept in continent ileostomy receives CE marking.

CE-marking for the TIES® System


Today, OstomyCure is very pleased to announce that the TIES® System has received approval for CE marking from our Notified Body.

Technical File submitted for CE approval of TIES®


Comprising an implantable medical device, the TIES® System requires approval from a Notified Body in order to obtain CE marking and to be marketed in Europe.

TIES® clinical study fully enrolled


The ongoing TIES® clinical study is moving forward and is now fully enrolled with the planned number of patients.

OstomyCure audit upgrade to Annex II in MDD


OstomyCure certification was upgraded to a higher level.